Motility® — Where Science Moves the Gut

 Motility®, Misk Pharma’s first generic Prucalopride in MENA, introduces a targeted prokinetic approach to chronic idiopathic constipation.

Unlike conventional laxatives, Prucalopride reactivates colonic motility at its source, delivering consistent bowel function, sustained symptom improvement, and enhanced patient quality of life—supported by robust clinical evidence and a strong safety profile.

Motility® is proudly manufactured in Jordan under global GMP standards, reaffirming Misk Pharma’s leadership in advanced gastroenterology solutions